Polyphen2 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (14)
Papers in which this entity is mentioned.
- CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods. (2024)
- Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
- dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. (2020)
- Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
- GAVIN: Gene-Aware Variant INterpretation for medical sequencing. (2017)
- Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines. (2017)
- CScape: a tool for predicting oncogenic single-point mutations in the cancer genome. (2017)
- New insights into the generation and role of de novo mutations in health and disease. (2016)
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. (2016)
- The human gene damage index as a gene-level approach to prioritizing exome variants. (2015)
- Genetic linkage analysis in the age of whole-genome sequencing. (2015)
- MBASED: allele-specific expression detection in cancer tissues and cell lines. (2014)
- Genic intolerance to functional variation and the interpretation of personal genomes. (2013)
- Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. (2009)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| polyphen | drug | 9 | 13 |
| polyphen-2 | drug | 8 | 19 |
| polyphen2 | drug | 8 | 12 |
| polyphen2 hdiv | drug | 1 | 1 |
| polyphen2 [hdiv] | drug | — | — |